Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
MEI Pharma Inc (MEIP)  
$3.06 0.00 (0.00%) as of 4:30 Wed 5/1


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 66,620,000
Market Cap: 203.86(M)
Last Volume: 14,666 Avg Vol: 14,625
52 Week Range: $3.05 - $7.84
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MEI Pharma is a late-stage pharmaceutical company focused on the development and commercialization of cancer therapies to improve outcomes for patients. Co.'s portfolio of drug candidates includes three clinical-stage assets, including: Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor; Voruciclib, an oral cyclin-dependent kinase 9 inhibitor; and ME-344, a mitochondrial inhibitor targeting the oxidative phosphorylation complex.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 336,100 417,600
Total Buy Value $0 $0 $2,112,595 $2,130,933
Total People Bought 0 0 2 3
Total Buy Transactions 0 0 6 7
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 54
  Page 2 of 3  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2019-12-19 4 B $1.60 $30,000 D/D 18,750 361,632 2.81     -
   Reynolds Thomas C Director   –       •      –    2019-12-19 4 B $1.60 $16,000 D/D 10,000 10,000 2.39     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2019-09-27 4 OE $1.57 $31,400 D/D 20,000 342,882     -
   White Christine Anna Director   –       •      –    2019-09-06 4 B $1.74 $26,075 D/D 15,000 15,000 2.39     -
   Urso David M Chief Operating Officer & GC   •       –      –    2018-08-07 4 S $3.58 $34,044 D/D (9,500) 24,106     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2018-08-06 4/A D $3.75 $191,018 D/D (50,938) 322,882     -
   Urso David M Chief Operating Officer & GC   •       –      –    2018-08-06 4 D $3.75 $66,615 D/D (17,764) 33,606     -
   Mass Robert D. Chief Medical Officer   •       –      –    2018-08-06 4 D $3.75 $66,409 D/D (17,709) 33,661     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2018-08-06 4 D $3.75 $202,849 D/D (54,093) 319,727     -
   Gold Daniel P Phd Chief Executive Officer   •       •      –    2018-03-29 4 D $2.07 $266,864 D/D (128,920) 271,080     -
   Baltic Charles V. Iii Director   –       •      –    2017-11-27 4 B $2.25 $24,801 D/D 11,000 24,250 2.39     -
   Baltic Charles V. Iii Director   –       •      –    2017-11-27 4 S $2.21 $24,272 D/D (11,000) 13,250     -
   Drazba Brian G. Chief Financial OfficerOfficer   •       –      –    2017-04-03 3 IO $0.00 $0 D/D 0 25,000     -
   Vivo Ventures V, Llc 10% Owner   •       •       •   2015-11-09 4 S $1.75 $15,999 I/I (9,142) 183,767     -
   Vivo Ventures Vii, Llc 10% Owner   •       •       •   2015-11-09 4 S $1.75 $275,366 I/I (157,352) 3,163,105     -
   Vivo Ventures V, Llc 10% Owner   •       •       •   2015-11-06 4 S $1.85 $814 I/I (440) 192,909     -
   Vivo Ventures Vii, Llc 10% Owner   •       •       •   2015-11-06 4 S $1.85 $13,986 I/I (7,560) 3,320,457     -
   Vivo Ventures V, Llc 10% Owner   •       •       •   2015-11-05 4 S $1.91 $25,042 I/I (13,111) 193,349     -
   Vivo Ventures Vii, Llc 10% Owner   •       •       •   2015-11-05 4 S $1.91 $431,011 I/I (225,660) 3,328,017     -
   Ratcliffe Liam 10% Owner   –       –       •   2015-03-24 4 S $1.97 $3,160,183 D/D (1,601,390) 0     -
   Vivo Ventures Vii, Llc   –       –       •   2015-03-24 4 A $3.12 $1,420,143 I/I 455,174 3,553,677     -
   Vivo Ventures V, Llc   –       –       •   2015-03-24 4 A $3.12 $82,508 I/I 26,445 206,460     -
   Baltic Charles V. Iii Director   –       •      –    2015-01-21 4 B $3.81 $19,050 D/D 5,000 24,250 2.39     -
   Baltic Charles V. Iii Director   –       •      –    2014-12-31 4 B $4.26 $6,390 I/I 1,500 5,350 2.1     -
   Baltic Charles V. Iii Director   –       •      –    2014-12-31 4 B $4.28 $6,420 D/D 1,500 19,250 2.39     -
  54 Records found
  1  2  3   
  Page 2 of 3
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us